AzTrials
AzTrials

Acute Kidney InjuryDRRRINCT05866250

Dynamic Change of Doppler-based Renal Resistive Index in Predicting Renal Recovery

An observational study of Acute Kidney Injury, run by The First Hospital of Jilin University at 7 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to observe the correlation between dynamic changes in the Doppler-based renal resistive index (RI) and the occurrence of persistent acute kidney injury (AKI) in critically ill patients. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Acute Kidney Injury
What is being tested?
Doppler-based renal resistive index
How many people
467 participants
Where
7 sitesChina
Study dates
1 Aug 2023to 1 Mar 2024
How long will I take part?
28 Days
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All the critically ill patients

Who may be able to join

  • Patients admitted to the ICU within 24 h of admission.

Who cannot join

  • Chronic kidney disease stage III-V;
  • History of kidney transplantation;
  • Previously known renal artery stenosis or renal vein thrombosis;
  • Cardiac arrhythmia precluding renal Doppler measurement;
  • Expected hospital stay < 72 h;
  • Pregnant patients
  • Last, patients with hospital stays < 72 h, since they could not be classified as having transient or persistent AKI according to our definitions, were secondarily excluded.

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

China7 sites
  • Jilin Province People's Hospital

    Changchun, Jlin, 130021

  • The First Hospital of Jilin University

    Changchun, Jlin, 130021

  • The Third Affiliated Hospital of Changchung University

    Changchun, Jlin, 130021

  • Dunhua City Hospital

    Dunhua, Jlin, 133799

  • Jilin Central Hospital

    Jilin City, Jlin, 132011

  • Meihekou Central Hospital

    Meihekou, Jlin, 135099

  • Jilin Siping Central People's Hospital

    Siping, Jlin, 132011

Other trials in China

About this study

Official title: Dynamic Change of Doppler-based Renal Resistive Index in Predicting Renal Recovery From Acute Kidney Injury in Critically Ill Patients: a Prospective Observational Multicenter Study

The goal of this observational study is to observe the correlation between dynamic changes in the Doppler-based renal resistive index (RI) and the occurrence of persistent acute kidney injury (AKI) in critically ill patients. The main questions it aims to answer are:

  • Are dynamic changes of RI within 24 or 48 hours associated with the prognosis of AKI (NO AKI, transient AKI, persistent AKI)?
  • what are the influencing factors of changes in RI? Participants will measure values of RI in patients at admission (0 hour), after 24 hours and after 48 hours, respectively, and collect characters such as age, sex, vital signs, Apache II, diagnosis, renal function, applied drugs, fluid, 72-hour renal function and renal replacement, followed renal replacement and the mortality rate at 28 days.
Read the detailed description

NO AKI is defined as No AKI occurred within 72 hour after ICU admission; Transient AKI is defined as AKI with recovery, which refers to the reduction in AKI stage ( (i.e., a decrease of serum creatinine, reversal of oliguria without diuretic therapy, and without need for renal replacement therapy) occurring with 72 hour after ICU admission; Persistent AKI is defined as AKI without recovery occurring with 72 hour after ICU admission.

Being tested
Doppler-based renal resistive index
Keywords
acute kidney injury, renal resistive index, prognosis, critically ill patients
Medical subject headings
Acute Kidney Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Doppler-based renal resistive indexDiagnostic test

    The kidney's interlobular or arcuate artery was preferentially selected and measured by pulse-wave Doppler.

Study groups in NCT05866250
Study groupRoleWhat they receive
critically ill patientsAll newly admitted ICU patients
Receives: Diagnostic Test: Doppler-based renal resistive index

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The prognosis of AKI

    NO AKI, transient AKI, persistent AKI. Transient AKI refers to the reduction in AKI stage ( (a decrease of serum creatinine, reversal of oliguria without diuretic therapy, and without need for renal replacement therapy) occurring with 72 hour after ICU admission. Persistent AKI refers to AKI without recovery occurring within 72 hours after ICU admission.

    Measured: 72 hours

Secondary outcomes (2)
  1. Recovery of kidney function

    A decrease of serum creatinine, reversal of oliguria without diuretic therapy, and without need for renal replacement therapy.

    Measured: 28 days

  2. Mortality

    Death or suivival

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2023
  2. Study start1 Aug 2023
  3. Primary completion30 Dec 2023
  4. Study completion1 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
467 participants (actual)
Target duration
28 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT05866250
Sponsor's protocol ID
DongZhang
Acronym
DRRRI
Status last verified
May 2024
First submitted
10 May 2023
Last updated
16 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015 Aug;41(8):1411-23. doi: 10.1007/s00134-015-3934-7. Epub 2015 Jul 11.

    PubMed 26162677
  • Darmon M, Schortgen F, Vargas F, Liazydi A, Schlemmer B, Brun-Buisson C, Brochard L. Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients. Intensive Care Med. 2011 Jan;37(1):68-76. doi: 10.1007/s00134-010-2050-y. Epub 2010 Sep 23.

    PubMed 20862450
  • Saade A, Bourmaud A, Schnell D, Darmon M; R2D2 Study Group. Performance of Doppler-Based Resistive Index and Semiquantitative Renal Perfusion in Predicting Persistent Acute Kidney Injury According to Operator Experience: Post Hoc Analysis of a Prospective Multicenter Study. Crit Care Med. 2022 Apr 1;50(4):e361-e369. doi: 10.1097/CCM.0000000000005372.

    PubMed 34678845
  • Schnell D, Bourmaud A, Reynaud M, Rouleau S, Merdji H, Boivin A, Benyamina M, Vincent F, Lautrette A, Leroy C, Cohen Y, Legrand M, Morel J, Terreaux J, Darmon M. Performance of renal Doppler to predict the occurrence of acute kidney injury in patients without acute kidney injury at admission. J Crit Care. 2022 Jun;69:153983. doi: 10.1016/j.jcrc.2021.12.017. Epub 2022 Jan 21.

    PubMed 35074631
  • Darmon M, Bourmaud A, Reynaud M, Rouleau S, Meziani F, Boivin A, Benyamina M, Vincent F, Lautrette A, Leroy C, Cohen Y, Legrand M, Morel J, Terreaux J, Schnell D. Performance of Doppler-based resistive index and semi-quantitative renal perfusion in predicting persistent AKI: results of a prospective multicenter study. Intensive Care Med. 2018 Nov;44(11):1904-1913. doi: 10.1007/s00134-018-5386-3. Epub 2018 Oct 5.

    PubMed 30291377
  • Fu Y, Ke L, Lv C, Wang Y, Zhang S, Yan J, Zhang X, Liu W, Hu Y, Zhang D, Li H. Early renal perfusion phenotypes and renal recovery in critically ill patients with or at risk for acute kidney injury: a prospective multicenter cohort study. Shock. 2026 Sep 7. doi: 10.1097/SHK.0000000000002936. Online ahead of print.

    PubMed 42704056

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Kidney Injury, run by The First Hospital of Jilin University at 7 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The prognosis of AKI (time frame: 72 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05866250, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2024; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in